E. Castermans

发表

Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers

Ton N Schumacher, Sine Reker Hadrup, T. Schumacher, 2009, Nature Methods.

Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa

V. Bours, V. Dideberg, L. Rostomyan, 2021, Endocrine connections.

Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease.

F. Baron, L. de Leval, S. Rahmouni, 2013, Cytotherapy.

Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning

F. Baron, R. Cheynier, V. Geenen, 2008, Haematologica.

Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection.

T. Schumacher, A. Bertoletti, Y. Khudyakov, 2011, Journal of hepatology.

X-linked Acrogigantism ( X-LAG ) Syndrome : Clinical Profile and Therapeutic Responses

Lim, Jean-François, J. Lupski, 2015 .

X-linked acrogigantism syndrome: clinical profile and therapeutic responses.

J. Lupski, F. Faucz, Jacques Young, 2015, Endocrine-related cancer.

A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).

W. Desmet, J. Balligand, S. Carlier, 2018, Atherosclerosis.

GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency

V. Bours, C. Stratakis, A. Barlier, 2016, Hormone and Metabolic Research.

Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-κB Inhibition and Gene Expression Signature

M. Merville, V. Bours, L. de Leval, 2006, Molecular Pharmacology.

Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions.

V. Bours, A. J. van der Lely, A. Beckers, 2018, Endocrine-related cancer.

Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age

R. Storb, F. Baron, B. Sandmaier, 2011, Haematologica.

GHRH excess and blockade in X-LAG syndrome.

C. Raftopoulos, V. Bours, C. Stratakis, 2016, Endocrine-related cancer.

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

P. Chanson, A. Tabarin, E. Baudin, 2015, European journal of endocrinology.

Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.

P. Chanson, A. Tabarin, E. Baudin, 2013, Human molecular genetics.

Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology.

R. Cheynier, R. Sékaly, M. Moutschen, 2003, The Journal of endocrinology.

Despite Inhibition of Hematopoietic Progenitor Cell Growth In Vitro, the Tyrosine Kinase Inhibitor Imatinib Does Not Impair Engraftment of Human CD133+ Cells into NOD/SCIDβ2mNull Mice

F. Baron, R. Greimers, E. Castermans, 2006, Stem cells.

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

P. Chanson, V. Bours, J. Bertherat, 2015, Endocrine-related cancer.

Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects.

J. Lupski, F. Faucz, V. Bours, 2016, Endocrine-related cancer.

Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.

J. Lupski, J. Wess, P. Chanson, 2014, The New England journal of medicine.

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

F. Baron, V. Bours, G. Fillet, 2003, Transplantation.

Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial.

F. Baron, G. Fillet, E. Castermans, 2005 .

Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening

V. Bours, L. Rostomyan, A. Beckers, 2016, Pituitary.

Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion

E. Korpershoek, V. Bours, V. Dideberg, 2020, Hormone and Metabolic Research.

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center

V. Bours, A. Soto-Moreno, A. Beckers, 2019, Endocrine connections.

What is the Contribution of Host-Derived CMV Immunity after Allogeneic Transplantation following Non-Myeloablative Conditioning?

F. Baron, E. Castermans, M. Hannon, 2012 .

Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age.

R. Storb, F. Baron, B. Sandmaier, 2009 .

What Is The Role For Regulatory T-Cells After Nonmyeloablative Conditioning?

F. Baron, E. Castermans, M. Hannon, 2008 .

Bone marrow-derived mesenchymal stromal cells failed to prevent experimental xenogeneic graft-versus-host disease

F. Baron, S. Rahmouni, L. Leval, 2012 .

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

L. Cavazzini, A. Beckers, M. Zatelli, 2014, Familial Cancer.

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis

V. Bours, F. Jouret, J. Krzesinski, 2014, Clinical kidney journal.

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

L. Cavazzini, A. Beckers, M. Zatelli, 2014, Familial Cancer.

W. Desmet, J. Balligand, S. Carlier, 2018, Atherosclerosis.

X-linked acrogigantism syndrome: clinical profile and therapeutic responses.

J. Lupski, F. Faucz, Jacques Young, 2015, Endocrine-related cancer.